Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor)

Clin Lung Cancer. 2023 May;24(3):e113-e116. doi: 10.1016/j.cllc.2022.12.004. Epub 2022 Dec 26.

¹ Department of Internal Medicine, William Beaumont Hospital, Royal Oak, MI: 3601 W Thirteen Mile Rd, Royal Oak, MI, USA 48073. Electronic address: ghimirebipin329@gmail.com.
² Department of Pathology, William Beaumont Hospital, Royal Oak, MI: 3601 W Thirteen Mile Rd, Royal Oak, MI, USA 48073.
³ Department of Internal Medicine, William Beaumont Hospital, Royal Oak, MI: 3601 W Thirteen Mile Rd, Royal Oak, MI, USA 48073.
⁴ Department of Hematology-Oncology, William Beaumont Hospital, Royal Oak, MI: 3601 W Thirteen Mile Rd, Royal Oak, MI, USA 48073.

No abstract available

Keywords: ALK inhibitors; ALK positive; Alectinib; Neuroendocrine tumor of lung; Survival.

Publication types